Abstract
Antigenic peptide is presented to a T-cell receptor through the formation of a stable complex with a Major Histocompatibility Complex (MHC) molecule. Various predictive algorithms have been developed to estimate a peptide’s capacity to form a stable complex with a given MHC Class II allele, a technique integral to the strategy of vaccine design. These have previously incorporated such computational techniques as quantitative matrices and neural networks. We have developed a novel predictive technique that uses molecular modeling of predetermined crystal structures to estimate the stability of an MHC Class II peptide complex. This is the 1st structure-based technique, as previous methods have been based on binding data. ROC curves are used to quantify the accuracy of the molecular modeling technique. The novel predictive technique is found to be comparable with the best predictive software currently available.
Similar content being viewed by others
References
Germain RN, Hendrix LR. (1991) MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134–9.
McFarland BJ, Beeson C. (2002) Binding interactions between peptides and proteins of the class II major histocompatibility complex. Med. Res. Rev. 22: 168–203.
Madden DR. (1995) The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587–622.
Chelvanayagam G, Easteal S. (1997) Peptides: two-faced, cheating go-betweens? Limits in the cellular immune system. Immunogenetics 46:516–9.
Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. (1996) Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl. Acad. Sci. U.S.A. 93:734–8.
Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F. (1994) Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353–8.
Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213–9.
Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP, Sinigaglia F, Hammer J. (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17:555–61.
Brusic V, Rudy G, Honeyman G, Hammer J, Harrison L. (1998) Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 14:121–30.
Brünger AT, Adam PD, Rice LM. (1997) New applications of simulated annealing in X-ray crystallography and solution NMR. Structure 5:325–34.
Hansson T, Oostenbrink C, van Gunsteren WF. (2002) Molecular dynamics simulations. Curr. Opin. Struc. Biol. 12:190–6.
Murthy VL, Stern LJ. (1997) The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 5:1385–96.
Kleywegt GJ, Jones TA. (1997) Model-building and refinement practice. Methods Enzymol. 277:208–30.
Case DA et al. (1999) AMBER 6. San Francisco,CA, Univ. of California.
Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE III, DeBolt S, Ferguson DM, Seibel GL, Kollman PA. (1995) AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp. Physics Communic. 91:1–41.
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926–35.
Marshall KW, Liu AF, Canales J, Perahia B, Jorgensen B, Gantzos RD, Aguilar B, Devaux B, Rothbard JB. (1994) Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol. 152:4946–57.
Swets J. (1988) Measuring the accuracy of diagnostic systems. Science 240: 1285–93.
Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A, Maillere B. (2000) HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 164:3177–84.
Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A. (1998) Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160:3363–73.
Sette A, Buus S, Appella E, Smith JA, Chesnut R, Miles C, Colon SM, Grey HM. (1989) Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl. Acad. Sci. U.S.A. 86(9):3296–300.
Gulukota K, Sidney J, Sette A, DeLisi C. (1997) Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol. 267:1258–67.
Zarutskie JA, Sato AK, Rushe MM, Chan IC, Lomakin A, Benedek GB, Stern LJ. (1999) A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. Biochemistry 38:5878–87.
Foster I, Kesselman C, Tuecke S. (2001) The anatomy of the grid: enabling scalable virtual organizations. Intl. J. Supercomputer Applic. 15(3):1–25.
Acknowledgments
MN Davies would like to thank the Biotechnology and Biological Sciences Research Council and the Anthony Nolan Research Institute for their financial support. The authors would also like to extend their thanks to Dr Andy Purkiss for his help in setting up the simulations and Dr Paul Travers for his advice on all things immunological.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davies, M.N., Sansom, C.E., Beazley, C. et al. A Novel Predictive Technique for the MHC Class II Peptide-Binding Interaction. Mol Med 9, 220–225 (2003). https://doi.org/10.2119/2003-00032.Sansom
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2119/2003-00032.Sansom